Skip to main content
Frontiers in Genetics logoLink to Frontiers in Genetics
. 2023 May 23;14:1204421. doi: 10.3389/fgene.2023.1204421

Corrigendum: Systematic pan-cancer analysis of the potential tumor diagnosis and prognosis biomarker P4HA3

Yinteng Wu 1,, Bo Zhang 2,, Juan Nong 3,, Raquel Alarcon Rodriguez 4, Wenliang Guo 5, Ying Liu 6, Shijian Zhao 7,*, Ruqiong Wei 6,*
PMCID: PMC10242340  PMID: 37287535

In the published article, there was an error in Figure 1D as published. The figure was misspelled during the rework process. The corrected Figure 1 and its caption are given below.

FIGURE 1.

FIGURE 1

Expression of P4HA3 in normal and tumor tissues. (A) P4HA3 expression across 31 regular tissues and (B) 21 tumor cell lines. The mRNA expression landscape of P4HA3 in (C) tumor tissue on TCGA database and (D) expression of P4HA3 in normal and tumor tissues (*p < 0.05, **p < 0.01, and ***p < 0.001; ns: no significance). p values were based on the Wilcoxon rank sum test.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Genetics are provided here courtesy of Frontiers Media SA

RESOURCES